Citation Impact
Citing Papers
Quercetin promotes antipromastigote effect by increasing the ROS production and anti-amastigote by upregulating Nrf2/HO-1 expression, affecting iron availability
2019
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
Human African trypanosomiasis
2009
Panowamycins A and B, new antitrypanosomal isochromans produced by Streptomyces sp. K07-0010
2012 StandoutNobel
Schistosomiasis
2018 Standout
Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis
2014
Ivermectin: panacea for resource-poor communities?
2014 StandoutNobel
The ChEMBL database in 2017
2016 Standout
Repurposing drugs for the treatment and control of helminth infections
2014
Potentiality of vanadium compounds as anti-parasitic agents
2011
3d Transition Metals for C–H Activation
2018 Standout
Challenges and Opportunities for the Application of Boron Clusters in Drug Design
2016
'Mode 3' and 'Quadruple Helix': toward a 21st century fractal innovation ecosystem
2009 Standout
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
2020 Standout
Knowledge production of firms: research networks and the "scientification" of business R&D
2005
Effect of ivermectin on trypanosoma brucei brucei in experimentally infected mice
2012
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Drugs for Neglected Diseases Initiative Model of Drug Development for Neglected Diseases: Current Status and Future Challenges
2011
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Management control systems across different modes of innovation: Implications for firm performance
2015 Standout
The Choice of Interactive Control Systems under Different Innovation Management Modes
2009
Works of Robert Don being referenced
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis
2015
Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis
2013
Potential Drug Development Candidates for Human Soil-Transmitted Helminthiases
2011
New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients
2009
Towards a fourth generation R&D management model-research networks in knowledge management
1999
Benzoxaboroles: A New Class of Potential Drugs for Human African Trypanosomiasis
2011
Development of Novel Drugs for Human African Trypanosomiasis
2011